Michelle Bentata

1.2k total citations
16 papers, 616 citations indexed

About

Michelle Bentata is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, Michelle Bentata has authored 16 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Virology and 4 papers in Oncology. Recurrent topics in Michelle Bentata's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (6 papers). Michelle Bentata is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (6 papers). Michelle Bentata collaborates with scholars based in France and United States. Michelle Bentata's co-authors include B Rueff, Claude Degott, Jean‐Philippe Miguet, Dominique Pessayre, O Nouël, Jean‐Pierre Benhamou, Dominique Costagliola, Clotilde Allavena, Pascale Fabbro-Péray and Sophie Grabar and has published in prestigious journals such as Gastroenterology, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Michelle Bentata

16 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Bentata France	10	308	237	170	136	125	16	616
Simona Landonio Italy	17	615 2.0×	335 1.4×	203 1.2×	26 0.2×	107 0.9×	32	776
D.M. Burger Netherlands	12	364 1.2×	193 0.8×	70 0.4×	49 0.4×	44 0.4×	27	461
L. Tong United States	8	529 1.7×	261 1.1×	123 0.7×	27 0.2×	53 0.4×	10	648
Daniel Seekins United States	19	532 1.7×	324 1.4×	211 1.2×	63 0.5×	53 0.4×	30	746
Dion F. Coakley United States	18	782 2.5×	536 2.3×	390 2.3×	24 0.2×	176 1.4×	25	1.2k
Lloyd Curtis United States	8	358 1.2×	285 1.2×	79 0.5×	25 0.2×	40 0.3×	12	498
Amy Cutrell United States	13	752 2.4×	581 2.5×	227 1.3×	41 0.3×	37 0.3×	18	1.1k
Michael L. Lim United States	9	502 1.6×	305 1.3×	99 0.6×	34 0.3×	21 0.2×	11	574
Aurélie Barrail‐Tran France	16	387 1.3×	194 0.8×	112 0.7×	44 0.3×	36 0.3×	35	639
Claire Raskino United States	12	307 1.0×	365 1.5×	103 0.6×	89 0.7×	59 0.5×	19	713

Countries citing papers authored by Michelle Bentata

Since Specialization

Citations

This map shows the geographic impact of Michelle Bentata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Bentata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Bentata more than expected).

Fields of papers citing papers by Michelle Bentata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Bentata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Bentata. The network helps show where Michelle Bentata may publish in the future.

Co-authorship network of co-authors of Michelle Bentata

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Bentata. A scholar is included among the top collaborators of Michelle Bentata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Bentata. Michelle Bentata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Assoumou, Lambert, Christine Katlama, Jean‐Paul Viard, et al.. (2013). Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia. AIDS. 27(15). 2425–2430. 33 indexed citations

Abgrall, Sophie, Lionel Fugon, Michelle Bentata, et al.. (2013). Visiting One’s Native Country. Journal of the International Association of Providers of AIDS Care (JIAPAC). 12(6). 407–413. 13 indexed citations

Rozenberg, Sylvie, Émilie Lanoy, Michelle Bentata, et al.. (2012). Effect of Alendronate on HIV-Associated Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled, 96-Week Trial (ANRS 120). AIDS Research and Human Retroviruses. 28(9). 972–980. 37 indexed citations

Mary‐Krause, Murielle, Jean‐Paul Viard, Michelle Bentata, et al.. (2012). Prevalence of Low Bone Mineral Density in Men and Women Infected With Human Immunodeficiency Virus 1 and a Proposal for Screening Strategy. Journal of Clinical Densitometry. 15(4). 422–433. 17 indexed citations

Viard, Jean‐Paul, Catherine Fagard, Marie‐Laure Chaix, et al.. (2009). Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients. AIDS. 23(11). 1383–1388. 9 indexed citations

Jeantils, Vincent, et al.. (2009). Utilisation de l’enfuvirtide chez la femme enceinte séropositive VIH, à propos de sept cas. Gynécologie Obstétrique & Fertilité. 37(5). 396–400. 3 indexed citations

Landman, Roland, Catherine Capitant, Diane Descamps, et al.. (2009). Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. Journal of Antimicrobial Chemotherapy. 64(1). 118–125. 7 indexed citations

Allavena, Clotilde, Virginie Ferré, Jean‐François Delfraissy, et al.. (2005). Efficacy and Tolerability of a Nucleoside Reverse Transcriptase Inhibitor-Sparing Combination of Lopinavir/Ritonavir and Efavirenz in HIV-1-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 39(3). 300–306. 28 indexed citations

Landman, Roland, Diane Descamps, Gilles Peytavin, et al.. (2005). Early Virologic Failure and Rescue Therapy of Tenofovir, Abacavir, and Lamivudine for Initial Treatment of HIV-1 Infection: TONUS Study. HIV Clinical Trials. 6(6). 291–301. 33 indexed citations

10.

Rozenbaum, Willy, Christine Katlama, Patrice Massip, et al.. (2001). Treatment Intensification with Abacavir in HIV-Infected Patients with at Least 12 Weeks Previous Lamivudine/Zidovudine Treatment. Antiviral Therapy. 6(2). 135–142. 6 indexed citations

11.

Morice, Yoann, Dominique Roulot, Véronique Grando, et al.. (2001). Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. Journal of General Virology. 82(5). 1001–1012. 90 indexed citations

12.

Grabar, Sophie, Christian Pradier, Rémi Lancar, et al.. (2000). Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS. 14(2). 141–149. 156 indexed citations

13.

Uzzan, Bernard, Michelle Bentata, José Campos, et al.. (1995). Effects of aerosolized pentamidine on glucose homeostasis, and insulin secretion in HIV-positive patients. AIDS. 9(8). 901–908. 4 indexed citations

14.

Bentata, Michelle, et al.. (1991). [Sarcoidosis in husband and wife].. PubMed. 118(11). 834–6. 1 indexed citations

15.

Pessayre, Dominique, Michelle Bentata, Claude Degott, et al.. (1977). Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.. PubMed. 72(2). 284–9. 98 indexed citations

16.

Pessayre, Dominique, Michelle Bentata, Claude Degott, et al.. (1977). Isoniazid-Rifampin Fulminant Hepatitis. Gastroenterology. 72(2). 284–289. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact